In vivo conversion of dopamine neurons in mouse models of Parkinson’s disease — a future approach for regenerative therapy?
| Autor: | Anders Björklund, Malin Parmar, Tomas Björklund |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Parkinson's disease
Biology Regenerative Medicine Regenerative medicine Mice 03 medical and health sciences 0302 clinical medicine In vivo Dopamine Parenchyma Genetics medicine Animals Humans 030304 developmental biology 0303 health sciences Dopaminergic Neurons Parkinson Disease medicine.disease 3. Good health Transplantation Disease Models Animal Stem cell Reprogramming Neuroscience 030217 neurology & neurosurgery Developmental Biology medicine.drug |
| Zdroj: | Current Opinion in Genetics & Development |
| ISSN: | 0959-437X |
| DOI: | 10.1016/j.gde.2021.06.002 |
| Popis: | Recent advances in cell reprogramming have made it possible to form new therapeutic cells within the body itself via a process called direct conversion or lineage reprogramming. A series of studies have shown that it is possible to reprogram resident glia into new neurons within the brain parenchyma. These studies opened up for the targeted attempts to achieve functional brain repair using in vivo conversion. Because of the relatively focal degeneration, Parkinson's Disease (PD) is an attractive target for both transplantation-based and in vivo conversion-based reparative approaches. Fetal cell transplants have provided proof-of-concept and stem cell-based therapies for PD are now on the verge of entering clinical trials. In the future, in vivo conversion may be an alternative to transplantation-based therapies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect